Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Rumana Rafiq et al.|Cancer Research|2013Cited by 367
Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover TrialBarry Wright, Jeremy N. V. Miles, David Sims et al.|Journal of Autism and Developmental Disorders|2010Cited by 194
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|Cancer Research|2021Cited by 49
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug responsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10